Fig. 1: TRIM52 expression in ovarian cancer.
From: TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway
a TRIKM52 expression in 568 ovarian cancer samples based on high-throughput RNA-sequencing data from TCGA, compared with noncancerous tissue (**P < 0.01). b The data from GESA showed that TRIM52 expression positively correlated with gene signatures involved in ovarian cancer metastasis. c The mRNA level of TRIN52 in 40 pairs of ovarian cancer and normal tissue was detected by qPCR. d Tissue microarray (TMA) study was employed to assess TRIM52 expression. The staining scores decided by immunohistochemistry experiment listed in di. dii, diii, div and dv showed the positive staining cells with the percentages of 5–25, 25–50, 50–75, and >75%, respectively
